SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-24-117574
Filing Date
2024-10-28
Accepted
2024-10-28 08:02:34
Documents
139
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A nams-20221231.htm   iXBRL 20-F/A 4878514
2 EX-2.4 nams-ex2_4.htm EX-2.4 112279
3 EX-12.1 nams-ex12_1.htm EX-12.1 15724
4 EX-12.2 nams-ex12_2.htm EX-12.2 15735
5 EX-13.1 nams-ex13_1.htm EX-13.1 8938
6 EX-13.2 nams-ex13_2.htm EX-13.2 8679
7 GRAPHIC img30326675_0.jpg GRAPHIC 149654
8 GRAPHIC img106017521_0.jpg GRAPHIC 161668
9 GRAPHIC img106017521_1.jpg GRAPHIC 667214
10 GRAPHIC img106017521_2.jpg GRAPHIC 670982
11 GRAPHIC img106017521_3.jpg GRAPHIC 772899
12 GRAPHIC img106017521_4.jpg GRAPHIC 685961
13 GRAPHIC img106017521_5.jpg GRAPHIC 82860
14 GRAPHIC img106017521_6.jpg GRAPHIC 76759
15 GRAPHIC img106017521_7.jpg GRAPHIC 73407
16 GRAPHIC img106017521_8.jpg GRAPHIC 1980
17 GRAPHIC img106017521_9.jpg GRAPHIC 117201
18 GRAPHIC img106017521_10.jpg GRAPHIC 101891
19 GRAPHIC img106017521_11.jpg GRAPHIC 53162
20 GRAPHIC img106017521_12.jpg GRAPHIC 581067
  Complete submission text file 0000950170-24-117574.txt   27363653

Data Files

Seq Description Document Type Size
21 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20221231.xsd EX-101.SCH 1865707
142 EXTRACTED XBRL INSTANCE DOCUMENT nams-20221231_htm.xml XML 3846408
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-41562 | Film No.: 241398455
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)